H. Casbolt

Toll‐like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension

N. Arnold, L. Farkas, E. Goncharova, 2019, American journal of respiratory and critical care medicine.

Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model

J. Iqbal, J. Gunn, Tooba Alizadeh, 2021, Journal of cardiovascular pharmacology.

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

N. Arnold, D. Crossman, N. Morrell, 2019, Nature Communications.

Multifaceted control of E-cadherin dynamics by Adaptor Protein Complex 1 during epithelial morphogenesis

N. Bulgakova, Miguel Ramírez Moreno, H. Casbolt, 2021, bioRxiv.

Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα

N. Rothwell, B. Nieswandt, S. Allan, 2014, Annals of neurology.

Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis

N. Arnold, C. Holt, S. Francis, 2017, Pulmonary circulation.

The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells

S. Wort, A. Lawrie, L. Ramakrishnan, 2018, Scientific Reports.